Misfolded proteins are observed in many genetic and sporadic forms of neurodegeneration and are associated with multiple neuronal disturbances. In some familial forms of disease, misfolding of the disease-related protein is due to mutations within the gene that encodes the protein. However, the mechanisms that underlie protein misfolding in other neurodegenerative diseases, in particular the sporadic, late-onset forms of these disorders, remain largely unknown. Our phenotype-driven approach has identified novel loss-of-function mutations that result in protein misfolding and neurodegeneration. In particular we have demonstrated that an editing mutation in the gene encoding alanyl tRNA synthetase (AlaRS) causes tRNA mischarging and accumulation of misfolded proteins in Purkinje cells. Importantly, also using a forward genetic approach, our laboratory has identified a novel gene, Stim, which cell-autonomously suppresses the accumulation of protein misfolding in these neurons and their subsequent degeneration. This proposal describes experiments to test the sensitivity of neurons, other than Purkinje cells, to mistranslation, via the generation of a mouse with a more severe deficiency in AlaRS editing. The function of Stim in other neurons will be tested in this model. We will also establish the role of Stim in the clearance of misfolded proteins via modulation of ubiquitin/proteasome system. Lastly, the effects of complete loss of Stim function will be assessed in mice with a conditional null mutation in this gene. Relevance of the proposed research to public health: The accumulation of abnormal proteins in neurons is associated with many human neurodegenerative disorders, including Parkinson's disease, Alzheimer's disease, Huntington's disease and ALS. The experiments outlined in this proposal will further define a novel gene that suppresses neuron death and the accompanying movement abnormalities that occur in response to the accumulation of abnormal proteins in Purkinje neurons in the cerebellum, the region of the brain that controls motor coordination. In addition, the ability of this gene to suppress neuronal dysfunction in other regions of the brain will be tested. The results from these experiments will potentially provide novel therapeutic targets for neuronal degenerative disorders.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Cellular and Molecular Biology of Neurodegeneration Study Section (CMND)
Program Officer
Gwinn, Katrina
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Jackson Laboratory
Bar Harbor
United States
Zip Code
Vo, My-Nuong; Terrey, Markus; Lee, Jeong Woong et al. (2018) ANKRD16 prevents neuron loss caused by an editing-defective tRNA synthetase. Nature 557:510-515
Liu, Ye; Satz, Jakob S; Vo, My-Nuong et al. (2014) Deficiencies in tRNA synthetase editing activity cause cardioproteinopathy. Proc Natl Acad Sci U S A 111:17570-5
Stum, Morgane; McLaughlin, Heather M; Kleinbrink, Erica L et al. (2011) An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations. Mol Cell Neurosci 46:432-43
Zhao, Lihong; Rosales, Christine; Seburn, Kevin et al. (2010) Alteration of the unfolded protein response modifies neurodegeneration in a mouse model of Marinesco-Sjogren syndrome. Hum Mol Genet 19:25-35
Zhao, Lihong; Ackerman, Susan L (2006) Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol 18:444-52
Klein, Jeffrey A; Ackerman, Susan L (2003) Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 111:785-93